ANSBERT GADICKE Insider Trading $CHMA CHIASMA, INC
Get free email notifications about insider trading for ANSBERT GADICKE.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of ANSBERT GADICKE. ANSBERT GADICKE is 10% Owner in RIGEL PHARMACEUTICALS INC ($RIGL) and Director in CHIASMA, INC ($CHMA) and Director in Radius Health, Inc. ($RDUS) and 10% Owner in Harpoon Therapeutics, Inc. ($HARP) and Director in Allovir, Inc. ($ALVR) and Director in TCR2 THERAPEUTICS INC. ($TCRR) and 10% Owner in Werewolf Therapeutics, Inc. ($HOWL) and 10% Owner in iTeos Therapeutics, Inc. ($ITOS) and Director in iTeos Therapeutics, Inc. ($ITOS) and 10% Owner in Repare Therapeutics Inc. ($RPTX) and Director in Cullinan Management, Inc. ($CGEM).
ANSBERT GADICKE in CHIASMA, INC
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of ANSBERT GADICKE: Director
Holdings: 5,681,544 shares
Current Value: $10,226,779
Latest Transaction: Jun 13 2016
$CHMA Market Capitalization: $43.85M
$CHMA Previous Close: $1.80
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD
Latest Insider Trading Transactions of ANSBERT GADICKE in CHIASMA, INC
| 1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
|---|---|---|---|---|---|---|---|
| No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Sentiment: All, ALVR, CHMA, CGEM, HARP, ITOS, RDUS, RPTX, RIGL, TCRR, HOWL
Page: 1
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Jun 13 2016 | CHMA | CHIASMA, INC | GADICKE ANSBERT | Director | Option Exercise | A | 3.14 | 10,000 | 31,400 | 10,000 | |
| Jul 21 2015 | CHMA | CHIASMA, INC | GADICKE ANSBERT | Director | Option Exercise | C | 0.00 | 13,000,000 | 0 | 0 | |
| Jul 21 2015 | CHMA | CHIASMA, INC | GADICKE ANSBERT | Director | Option Exercise | C | 0.00 | 16,066,669 | 0 | 0 | |
| Jul 21 2015 | CHMA | CHIASMA, INC | GADICKE ANSBERT | Director | Option Exercise | C | 0.00 | 22,721,988 | 0 | 0 | |
| Jul 21 2015 | CHMA | CHIASMA, INC | GADICKE ANSBERT | Director | Option Exercise | C | 0.00 | 95,225 | 0 | 0 | |
| Jul 21 2015 | CHMA | CHIASMA, INC | GADICKE ANSBERT | Director | Buy | C | 0.00 | 1,423,566 | 0 | 5,681,544 | 4.3 M to 5.7 M (+33.43 %) |
| Jul 21 2015 | CHMA | CHIASMA, INC | GADICKE ANSBERT | Director | Buy | C | 0.00 | 1,759,381 | 0 | 4,257,978 | 2.5 M to 4.3 M (+70.41 %) |
| Jul 21 2015 | CHMA | CHIASMA, INC | GADICKE ANSBERT | Director | Buy | C | 0.00 | 2,488,171 | 0 | 2,498,597 | 10.4 K to 2.5 M (+23,865.06 %) |
| Jul 21 2015 | CHMA | CHIASMA, INC | GADICKE ANSBERT | Director | Buy | C | 0.00 | 10,426 | 0 | 10,426 | 0 to 10.4 K |
Page: 1